Status:
COMPLETED
Safety and Feasibility Study of the Chartis System With Heterogeneous Emphysema Prior to Endobronchial Lung Volume Reduction (ELVR)
Lead Sponsor:
Pulmonx Corporation
Conditions:
Heterogeneous Emphysema
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to evaluate the safety and feasibility of the Chartis System in measuring air flow and pressures in isolated lung compartments in emphysema patients prior to endobronchial...
Eligibility Criteria
Inclusion
- Heterogeneous emphysema as determined by high-resolution CT scan
- Scheduled for clinically indicated ELVR procedure
Exclusion
- Hyperexcretive chronic bronchitis or excessive sputum secretion
- Active pulmonary infection
- Active asthma or lung hyper-responsiveness
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00684892
Start Date
May 1 2008
End Date
November 1 2008
Last Update
January 22 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thoraxklinik am Universitatsklinikum Heidelberg
Heidelberg, Germany, D-69126